The activated tumor specific T cells then migrate and infiltrate into the tumor bed to recognize TAAs bound on MHC class I of cancer cells through their TCR, leading to T cell-mediated cytotoxicity [42]. The gene discussed is HLA-C; the disease is neoplasm.